Tiverton Asset Management’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
$23M Buy
286,566
+49,349
+21% +$3.96M 0.8% 23
2019
Q2
$19M Buy
237,217
+54,069
+30% +$4.14M 0.68% 33
2019
Q1
$14.5M Buy
183,148
+49,676
+37% +$3.72M 0.63% 35
2018
Q4
$9.73M Buy
133,472
+74,639
+127% +$5.27M 0.58% 44
2018
Q3
$3.98M Sell
58,833
-1,102
-2% -$70.2K 0.2% 97
2018
Q2
$3.47M Buy
59,935
+31,402
+110% +$1.77M 0.17% 104
2018
Q1
$1.48M Sell
28,533
-1,457
-5% -$78.7K 0.1% 130
2017
Q4
$1.61M Buy
+29,990
New +$1.66M 0.1% 159

Other funds holding MRK

Tiverton Asset Management's MRK Position: Q3 2019 in Review

Tiverton Asset Management increased its Merck (MRK) stake by 21% in Q3 2019, buying an estimated $3.96M and bringing the position to 286,566 shares worth $23M. The position accounts for 0.8% of the portfolio, ranked #23.

Tiverton Asset Management first reported a position in MRK in Q4 2017 and has held it in 8 quarters since. 2,306 funds tracked by Wall St. Rank hold MRK as of Q3 2019.

  • Tiverton Asset Management held 286,566 shares of Merck worth $23M as of Q3 2019.
  • Tiverton Asset Management bought 49,349 Merck shares in Q3 2019, an estimated $3.96M.
  • Merck made up 0.8% of Tiverton Asset Management's portfolio in Q3 2019, its #23 holding.
  • Tiverton Asset Management first reported a position in Merck in Q4 2017 and has held it in 8 quarters since.
  • 2,306 funds tracked by Wall St. Rank held Merck as of Q3 2019.

Based on Tiverton Asset Management's 13F filing for Q3 2019, filed 13 Nov 2019.